GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (FRA:OLY1) » Definitions » YoY EBITDA Growth

Olympus (FRA:OLY1) YoY EBITDA Growth : 2,490.00% (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Olympus YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Olympus's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 2,490.00%.

Olympus's EBITDA per Share for the three months ended in Sep. 2024 was €0.24.

Olympus YoY EBITDA Growth Historical Data

The historical data trend for Olympus's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus YoY EBITDA Growth Chart

Olympus Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.19 -17.23 47.21 11.93 -60.06

Olympus Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -102.65 -26.09 -65.15 12.14 2,490.00

Olympus YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Olympus's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (A: Mar. 2024 )
=(EBITDA per Share (A: Mar. 2024 )-EBITDA per Share (A: Mar. 2023 ))/ | EBITDA per Share (A: Mar. 2023 ) |
=(0.566-1.417)/ | 1.417 |
=-60.06 %

Olympus's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (Q: Sep. 2024 )
=(EBITDA per Share (Q: Sep. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(0.239--0.01)/ | -0.01 |
=2,490.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olympus YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Olympus's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Olympus Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (FRA:OLY1) » Definitions » YoY EBITDA Growth
Comparable Companies
TSE:6869 TSE:4543 TSE:7747 TSE:8086 TSE:3360 TSE:7716 TSE:7730 TSE:3046 TSE:7817 TSE:7780 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B WST COO XSWX:STMN
Traded in Other Exchanges
OLYMY:USA OCPNF:USA 7733:Japan OLY1:Germany
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Website
http://www.olympus.co.jp
Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

Olympus Headlines

No Headlines